IGF-1 LR3 for Athletes
IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arg3) is a modified analogue of endogenous IGF-1 with a 20–30 hour half-life vs 12 minutes for the native peptide. It activates the IGF-1 receptor to drive muscle protein synthesis, satellite cell proliferation, and nutrient partitioning — making it one of the most potent anabolic peptides researched for athletic applications.
Why IGF-1 LR3 Works for Athletic Performance
IGF-1 LR3 binds the IGF-1 receptor and activates the PI3K/Akt/mTOR pathway — the primary intracellular signaling cascade for muscle protein synthesis. This directly drives lean mass accretion in response to resistance training.
Activates muscle satellite cells (stem cells), promoting their proliferation and differentiation into new muscle fibers. This is the mechanism by which IGF-1 LR3 can produce hyperplasia (new muscle fibers) in addition to hypertrophy (larger existing fibers).
Increases glucose uptake in muscle tissue and promotes amino acid transport into muscle cells, directing nutrients toward muscle protein synthesis rather than fat storage — particularly effective in the post-workout anabolic window.
The LR3 modification reduces binding affinity for IGF-binding proteins (IGFBPs) by ~500x. Since IGFBPs normally sequester ~99% of circulating IGF-1, this modification dramatically increases the proportion of bioavailable, active peptide.
IGF-1 LR3 Dosage Protocol for Athletes
| Level | Dose | Timing | Cycle Length | Notes |
|---|---|---|---|---|
| Beginner | 20–40mcg/day | Post-workout SubQ/IM | 4 weeks | Assess hypoglycemia tolerance; have carbs available |
| Intermediate | 50–80mcg/day | Post-workout SubQ/IM | 4–6 weeks | Most common athletic protocol; strong anabolic effect |
| Advanced | 80–100mcg/day | Post-workout bilateral IM | 4–6 weeks | Maximum research dose; significantly elevated hypoglycemia risk |
| Off cycle | None | 4–6 weeks | 4–6 weeks | Allow receptor desensitization to reset |
IGF-1 LR3 from Purgo Labs
≥99% purity, third-party COA verified, cGMP facility.
Use code HEALTH for 15% off.
Shop IGF-1 LR3Frequently Asked Questions
What is the best IGF-1 LR3 dose for athletes?
The most commonly researched dose range is 20–100mcg per day, injected subcutaneously or intramuscularly. Beginner protocols typically start at 20–40mcg/day. Intermediate protocols use 50–80mcg/day. Doses above 100mcg/day significantly increase the risk of hypoglycemia and are not recommended. Most athletes cycle IGF-1 LR3 for 4–6 weeks due to receptor desensitization.
When should athletes inject IGF-1 LR3?
Post-workout injection is the most common approach — the anabolic window immediately after training maximizes nutrient partitioning and muscle protein synthesis. Some athletes inject bilaterally into the trained muscle groups (intramuscular) to direct the anabolic effect locally. Fasting injection is avoided due to hypoglycemia risk; always inject with food or post-workout nutrition available.
How does IGF-1 LR3 differ from regular IGF-1?
IGF-1 LR3 has an arginine substitution at position 3 and a 13-amino acid extension at the N-terminus. This modification reduces its binding affinity for IGF-binding proteins (IGFBPs) by ~500x, meaning more of the peptide remains in its active, unbound form. The result is a half-life of 20–30 hours vs ~12 minutes for regular IGF-1, and significantly greater bioavailability.
Does IGF-1 LR3 cause hypoglycemia?
Yes — hypoglycemia is the primary risk with IGF-1 LR3. IGF-1 has insulin-like activity and can cause blood glucose to drop, particularly when injected in a fasted state or at high doses. Always inject post-workout with carbohydrate-containing nutrition available. Symptoms of hypoglycemia include dizziness, sweating, confusion, and shakiness. Start at the lowest effective dose (20mcg) and assess tolerance.
How long should athletes cycle IGF-1 LR3?
Most protocols recommend 4–6 week cycles with 4–6 weeks off. Longer continuous use leads to IGF-1 receptor downregulation (desensitization), reducing effectiveness. The off-cycle period allows receptor sensitivity to reset. Some athletes time cycles to coincide with high-intensity training blocks or competition preparation phases.
Is IGF-1 LR3 prohibited in sports?
Yes. IGF-1 and its analogues (including LR3) are classified under WADA's Prohibited List as peptide hormones (S2 category). Athletes subject to drug testing by WADA, USADA, or any major sports federation should not use IGF-1 LR3. This guide is for research and educational purposes only.